GDNF and Parkinson disease: In an animal model of PD (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model), sodium benzoate was also shown to affect levels of glial cell-derived neurotrophic factor (GDNF) [174].